Kamar N - Search Results

1

Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant.

Hage V, Ferrandiz I, Béllière J, Esposito L, Hebral AL, Cointault O, Del Bello A, Kamar N. Hage V, et al. Among authors: kamar n. Exp Clin Transplant. 2019 Jun;17(3):313-319. doi: 10.6002/ect.2018.0043. Epub 2018 Dec 31. Exp Clin Transplant. 2019. PMID: 30602364 Free article.

2

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

3

Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.

Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D. Cointault O, et al. Among authors: kamar n. Nephrol Dial Transplant. 2004 Jan;19(1):171-8. doi: 10.1093/ndt/gfg488. Nephrol Dial Transplant. 2004. PMID: 14671053

4

Villous atrophy induced by mycophenolate mofetil in renal-transplant patients.

Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, Moreau J, Rostaing L. Kamar N, et al. Transpl Int. 2004 Sep;17(8):463-7. doi: 10.1007/s00147-004-0745-0. Epub 2004 Aug 21. Transpl Int. 2004. PMID: 15322747 Free article.

5

Effects of long-term lamivudine therapy in renal-transplant patients.

Kamar N, Sandres-Saune K, Ribes D, Duffaut M, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. J Clin Virol. 2004 Dec;31(4):298-303. doi: 10.1016/j.jcv.2004.07.001. J Clin Virol. 2004. PMID: 15494273

6

Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients.

Mouzin M, Bachaud JM, Kamar N, Gamé X, Vaessen C, Rischmann P, Rostaing L, Malavaud B. Mouzin M, et al. Among authors: kamar n. Transplantation. 2004 Nov 27;78(10):1496-500. doi: 10.1097/01.tp.0000137933.97259.e7. Transplantation. 2004. PMID: 15599314

7

Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C.

Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssiere L, Durand D, Izopet J, Rostaing L. Kamar N, et al. Transplant Proc. 2004 Nov;36(9):2757-61. doi: 10.1016/j.transproceed.2004.10.003. Transplant Proc. 2004. PMID: 15621141

8

Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.

Kamar N, Borde JS, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssière L, Durand D, Izopet J, Rostaing L. Kamar N, et al. Clin Transplant. 2005 Feb;19(1):83-9. doi: 10.1111/j.1399-0012.2004.00302.x. Clin Transplant. 2005. PMID: 15659139

9

Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.

Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, Rostaing L, Izopet J. Kamar N, et al. Am J Kidney Dis. 2005 Jan;45(1):193-6. doi: 10.1053/j.ajkd.2004.09.006. Am J Kidney Dis. 2005. PMID: 15696460

10

Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.

Kamar N, Allard J, Ribes D, Durand D, Ader JL, Rostaing L. Kamar N, et al. Clin Nephrol. 2005 Feb;63(2):80-6. doi: 10.5414/cnp63080. Clin Nephrol. 2005. PMID: 15730049 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters